SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Germline selection shapes human mitochondrial DNA diversity.

Wei, W; Tuna, S; Keogh, MJ; Smith, KR; Aitman, TJ; Beales, PL; Bennett, DL; Gale, DP; Bitner-Glindzicz, MAK; Black, GC; et al. Wei, W; Tuna, S; Keogh, MJ; Smith, KR; Aitman, TJ; Beales, PL; Bennett, DL; Gale, DP; Bitner-Glindzicz, MAK; Black, GC; Brennan, P; Elliott, P; Flinter, FA; Floto, RA; Houlden, H; Irving, M; Koziell, A; Maher, ER; Markus, HS; Morrell, NW; Newman, WG; Roberts, I; Sayer, JA; Smith, KGC; Taylor, JC; Watkins, H; Webster, AR; Wilkie, AOM; Williamson, C; NIHR BioResource–Rare Diseases; 100,000 Genomes Project–Rare Diseases Pilot; Ashford, S; Penkett, CJ; Stirrups, KE; Rendon, A; Ouwehand, WH; Bradley, JR; Raymond, FL; Caulfield, M; Turro, E; Chinnery, PF (2019) Germline selection shapes human mitochondrial DNA diversity. Science, 364 (6442). eaau6520. ISSN 1095-9203 https://doi.org/10.1126/science.aau6520
SGUL Authors: Snape, Katie Mairwen Greenwood

[img]
Preview
PDF Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (2MB) | Preview

Abstract

Approximately 2.4% of the human mitochondrial DNA (mtDNA) genome exhibits common homoplasmic genetic variation. We analyzed 12,975 whole-genome sequences to show that 45.1% of individuals from 1526 mother-offspring pairs harbor a mixed population of mtDNA (heteroplasmy), but the propensity for maternal transmission differs across the mitochondrial genome. Over one generation, we observed selection both for and against variants in specific genomic regions; known variants were more likely to be transmitted than previously unknown variants. However, new heteroplasmies were more likely to match the nuclear genetic ancestry as opposed to the ancestry of the mitochondrial genome on which the mutations occurred, validating our findings in 40,325 individuals. Thus, human mtDNA at the population level is shaped by selective forces within the female germ line under nuclear genetic control, which ensures consistency between the two independent genetic lineages.

Item Type: Article
Additional Information: This is the author’s version of the work. It is posted here by permission of the AAAS for personal use, not for redistribution. The definitive version was published in Science on Vol 364 24 May 2019, DOI: 10.1126/science.aau6520.
Keywords: DNA, Mitochondrial, Female, Genetic Variation, Genome, Mitochondrial, Humans, Maternal Inheritance, Ovum, Selection, Genetic, NIHR BioResource–Rare Diseases, 100,000 Genomes Project–Rare Diseases Pilot, Ovum, Humans, DNA, Mitochondrial, Female, Genome, Mitochondrial, Genetic Variation, Selection, Genetic, Maternal Inheritance, General Science & Technology, MD Multidisciplinary
SGUL Research Institute / Research Centre: Academic Structure > Institute of Medical & Biomedical Education (IMBE)
Journal or Publication Title: Science
ISSN: 1095-9203
Language: eng
Dates:
DateEvent
24 May 2019Published
3 April 2019Accepted
Publisher License: Publisher's own licence
Projects:
Project IDFunderFunder ID
G0701386Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MR/M009203/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MR/J011711/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
SGP/1Chief Scientist Officehttp://dx.doi.org/10.13039/501100000589
MC_EX_MR/M009203/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MR/L019027/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
FS/12/82/29736British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
G1002570Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
G9521010Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
101876/Z/13/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
RP-2016-07-019Department of Healthhttp://dx.doi.org/10.13039/501100000276
MC_PC_14089Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MC_PC_15080Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
212219/Z/18/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
MC_UU_00015/9Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
090532/Z/09/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
201064/Z/16/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
109915/Z/15/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
203105/Z/16/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
MR/N025431/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
309548European Research Councilhttp://dx.doi.org/10.13039/501100000781
MR/N027302/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MR/M012212/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
FS/13/48/30453British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
ID633491Horizon 2020UNSPECIFIED
NNF14SA0006Novo Nordiskhttp://dx.doi.org/10.13039/501100004191
202747/Z/16/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
MR/L019027/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
090532Wellcome Trusthttp://dx.doi.org/10.13039/100004440
0938381Wellcome Trusthttp://dx.doi.org/10.13039/100004440
RG/16/4/32218British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
1570/1571Fight for Sighthttp://dx.doi.org/10.13039/100002089
24TP171Fight for Sighthttp://dx.doi.org/10.13039/100002089
IS-BRC-1215-20002National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
109915/Z/15/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
203105/Z/16/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
MR/N025431/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
309548European Research Councilhttp://dx.doi.org/10.13039/501100000781
201064/Z/16/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
MR/N027302/1Newton FundUNSPECIFIED
107469/Z/15/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
MR/R002363/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
RP-2016-07-019National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
098524/Z/12/AWellcome Trusthttp://dx.doi.org/10.13039/100004440
MR/L006340/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
WT098519MAWellcome Trusthttp://dx.doi.org/10.13039/100004440
PubMed ID: 31123110
Web of Science ID: WOS:000469296000033
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/112683
Publisher's version: https://doi.org/10.1126/science.aau6520

Actions (login required)

Edit Item Edit Item